News
September 25, 2019

Invest in the Future of Health Biotech, European Biotech Week

Invest in the Future of Health Biotech during the European Biotech Week 2019 (Brussels) "How…
Read More
News
June 3, 2019

S.A.B Meeting in Chicago, during ASCO 2019

Scientific Advisory Board Meeting during ASCO 2019   Chicago, USA, June 3, 2019 — Genoscience…
Read More
News
April 17, 2019

Chaim Hurvitz, New Board of Directors Member

Chaim Hurvitz, New Board of Directors Member   Chaim Hurvitz has joined  Genoscience Pharma Board…
Read More
News
December 10, 2018

Most Innovative European Biotech SME for 2018

Most Innovative European Biotech SME for 2018   Bruxelles, Belgium, December 3, 2018 - Company…
Read More
News
November 9, 2018

Raphaël Rodriguez: Winner 2019 Tetrahydron Young Investigator Award

Raphaël Rodriguez: Winner 2019 Tetrahydron Young Investigator Award   Institut Curie, France, November 9, 2018…
Read More
News
October 5, 2018

Extension to US of GNS561 Clinical Trial

Genoscience Pharma Extends to US its Clinical Trial in Patients with Advanced Liver Cancers  …
Read More
News
June 4, 2018

S.A.B. Meeting in Chicago, during ASCO 2018

Scientific Advisory Board Meeting during ASCO 2018   Chicago, USA, June 4, 2018 — During…
Read More
News
May 22, 2018

Extension to France of GN561 Clinical trial

Genoscience Pharma Extends its GNS561 Clinical Trial to France   Enrollment is open for patients…
Read More
News
April 5, 2018

First-in-human Dosing of GNS561 in Liver Cancer Patients

First-in-human Dosing of GNS561 in Patients with Advanced Liver Cancer at the Jules Bordet Institute,…
Read More
News
December 6, 2017

GNS561 Gets US FDA IND Approval in Liver Cancer

Genoscience Pharma Receives FDA Approval for Phase Ib/IIa Study of GNS561 in Liver Cancer  …
Read More
News
February 24, 2016

Four New Members in Our Directory Board

Four New Members in Our Directory Board   Marseille, France, February 24, 2016 – Genoscience Pharma…
Read More
News
February 6, 2012

BL-8030 worldwide License Agreement with BioLineRx

RFS Pharma and Genoscience Pharma enter Worldwide License Agreement with BioLineRx to develop and commercialize Hepatitis…
Read More
News
January 24, 2012

BL-8020 exclusive License Agreement with BioLineRx

BioLineRx signs exclusive License Agreement for BL-8020, an oral Hepatitis C treatment   Jerusalem, Israel,…
Read More
News
June 19, 2007

Joint Venture Agreement with RFS Pharma

RFS Pharma and Genoscience Pharma Sign Joint Venture Agreement to Discover and Develop Protease Inhibitors…
Read More